Generalized Anxiety Disorder (GAD)

Psychiatry

Overview

Definition

Excessive, uncontrollable, and often irrational worry about everyday things that is disproportionate to the actual source of worry.

Epidemiology

Lifetime prevalence ~5%. Twice as common in women.

Etiology & Risk Factors

  • Biological (dysregulation of GABA and serotonin systems), genetic predisposition, and environmental/psychological factors (chronic stress, trauma).

Clinical Symptoms

  • Excessive worry occurring more days than not
  • Restlessness or feeling on edge
  • Easily fatigued
  • Difficulty concentrating (mind going blank)
  • Irritability
  • Muscle tension
  • Sleep disturbance

Clinical Approach

Diagnosis

  • DSM-5 Criteria: Excessive worry for ≥ 6 months about various domains (work, school, health, family)
  • Must have ≥ 3 of the somatic symptoms listed above
  • Must cause significant distress or impairment

Management

  • First-line Pharmacotherapy: SSRIs (e.g., Escitalopram, Paroxetine) or SNRIs (Venlafaxine, Duloxetine)
  • First-line Psychotherapy: Cognitive Behavioral Therapy (CBT)
  • Short-term bridge therapy: Benzodiazepines (e.g., Clonazepam) can be used short-term while waiting for SSRIs to take effect (due to high addiction potential)
  • Buspirone (a non-habit-forming anxiolytic) as an adjunct

Complications

  • Severe impairment in occupational/social functioning
  • High comorbidity with Major Depressive Disorder (MDD) and substance abuse